Meta-analysis of the effect of rituximab in the treatment of primary central nervous system lymphoma

dc.contributor.authorYavuz, S.
dc.contributor.authorYildirim, M.
dc.contributor.authorYazici, G.
dc.contributor.authorKaya, V.
dc.contributor.authorPaydas, S.
dc.date.accessioned2025-10-16T15:26:54Z
dc.date.issued2017
dc.description.abstract42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid, SPAIN, SEP 08-12, 2017
dc.identifier.otherWOS:000411324000320
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/8454
dc.publisherOXFORD UNIV PRESS
dc.sourceANNALS OF ONCOLOGY
dc.titleMeta-analysis of the effect of rituximab in the treatment of primary central nervous system lymphoma
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar